Exhibit 99.1
Amended Loan Schedule to Secured Promissory Note dated November 10, 2022 between Acura Pharmaceuticals, Inc. and Abuse Deterrent Pharma, LLC
Date | Principal | Aggregated Principal | ||||||||
Original Secured Promissory Note | 11/10/2022 | $ | 2,319,279 | $ | 2,319,279 | |||||
Additional loans to be included: | ||||||||||
Loan #1 | 12/22/2022 | $ | 250,000 | $ | 2,569,279 | |||||
Loan #2 | 1/19/2023 | $ | 250,000 | $ | 2,819,279 | |||||
Loan #3 | 2/22/2023 | $ | 250,000 | $ | 3,069,279 | |||||
Loan #4 | 3/20/2023 | $ | 250,000 | $ | 3,319,279 | |||||
Loan #5 | 5/19/2023 | $ | 150,000 | $ | 3,469,279 | |||||
Loan #6 | 7/10/2023 | $ | 200,000 | $ | 3,669,279 | |||||
Loan #7 | 7/28/2023 | $ | 250,000 | $ | 3,919,279 | |||||
Loan #8 | 8/30/2023 | $ | 250,000 | $ | 4,169,279 | |||||
Loan #9 | 10/11/2023 | $ | 250,000 | $ | 4,419,279 | |||||
Loan #10 | 12/04/2023 | $ | 250,000 | $ | 4,669,279 | |||||
Loan #11 | 1/08/2024 | $ | 250,000 | $ | 4,919,279 | |||||
Loan #12 | 2/14/2024 | $ | 250,000 | $ | 5,169,279 |
ACURA PHARMACEUTICALS, INC. | ||
By: | /s/ Peter A. Clemens | |
Peter A. Clemens | ||
Senior Vice President & Chief Financial Officer | ||
Date: February 14, 2024 |